Azelaic acid

Azelaic acid is a lipid of Fatty Acyls (FA) class. Azelaic acid is associated with abnormalities such as Bacterial Infections and Infection. The involved functions are known as Anabolism, Signal Transduction, Plant Immunity, Signal and Signal Transduction Pathways. Azelaic acid often locates in Body tissue. The associated genes with Azelaic acid are AZI1 gene, FKBPL gene and MLL gene. The related lipids are sebacic acid.

Cross Reference

Introduction

To understand associated biological information of Azelaic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azelaic acid?

Azelaic acid is suspected in Infection, Bacterial Infections and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azelaic acid

PubChem Associated disorders and diseases

What pathways are associated with Azelaic acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Azelaic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azelaic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azelaic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azelaic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azelaic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azelaic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Azelaic acid

Download all related citations
Per page 10 20 50 100 | Total 511
Authors Title Published Journal PubMed Link
Elewski BE et al. In reference to the October 2004 comprehensive overview of rosacea therapy. 2007 J. Am. Acad. Dermatol. pmid:17870440
Gupta AK et al. The treatment of melasma: a review of clinical trials. 2006 J. Am. Acad. Dermatol. pmid:17097400
Maddin S A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. 1999 J. Am. Acad. Dermatol. pmid:10365928
Chen Z et al. Versatile synthesis strategy for carboxylic acid-functionalized upconverting nanophosphors as biological labels. 2008 J. Am. Chem. Soc. pmid:18278910
Bojar RA et al. The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37. 1991 J. Antimicrob. Chemother. pmid:1726169
Maple PA et al. Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. 1992 J. Antimicrob. Chemother. pmid:1506349
Bojar RA et al. Disruption of the transmembrane pH gradient--a possible mechanism for the antibacterial action of azelaic acid in Propionibacterium acnes and Staphylococcus epidermidis. 1994 J. Antimicrob. Chemother. pmid:7829407
Bojar RA et al. Azelaic acid: its uptake and mode of action in Staphylococcus epidermidis NCTC 11047. 1988 J. Appl. Bacteriol. pmid:2459099
Gołębiowski M et al. Antimicrobial activity of untypical lipid compounds in the cuticular and internal lipids of four fly species. 2014 J. Appl. Microbiol. pmid:24238211
Vermis K et al. Burkholderia cepacia complex genomovars: utilization of carbon sources, susceptibility to antimicrobial agents and growth on selective media. 2003 J. Appl. Microbiol. pmid:14632991
Shirokova E et al. Identification of specific ligands for orphan olfactory receptors. G protein-dependent agonism and antagonism of odorants. 2005 J. Biol. Chem. pmid:15598656
Yu JS and Kim AK Effect of combination of taurine and azelaic acid on antimelanogenesis in murine melanoma cells. 2010 J. Biomed. Sci. pmid:20804622
De Filippis D et al. Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats. 2009 J. Cell. Mol. Med. pmid:18429935
Nojima S et al. Contact sex pheromone components of the cowpea weevil, Callosobruchus maculatus. 2007 J. Chem. Ecol. pmid:17394050
Yoon TY et al. A case of idiopathic eruptive macular pigmentation. 2004 J. Dermatol. pmid:15187318
Erbil H et al. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma. 2007 J. Dermatol. pmid:17204097
Oh CW and Myung KB An ultrastructural study of the retention hyperkeratosis of experimentally induced comedones in rabbits: the effects of three comedolytics. 1996 J. Dermatol. pmid:8935627
Wittek F et al. Arabidopsis ENHANCED DISEASE SUSCEPTIBILITY1 promotes systemic acquired resistance via azelaic acid and its precursor 9-oxo nonanoic acid. 2014 J. Exp. Bot. pmid:25114016
Chae K et al. A multifaceted study of stigma/style cysteine-rich adhesin (SCA)-like Arabidopsis lipid transfer proteins (LTPs) suggests diversified roles for these LTPs in plant growth and reproduction. 2010 J. Exp. Bot. pmid:20667964
Yu L et al. Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry. 2011 J. Gastroenterol. Hepatol. pmid:21443661
JANOTA-BASSALIK L and WRIGHT LD AZELAIC ACID UTILIZATION BY A PSEUDOMONAS. 1964 J. Gen. Microbiol. pmid:14217352
Brune TG et al. Unknown peaks in GC-MS analyses of Guthrie cards blood samples might be the result of sample contamination by the black markings of the card. 2002 J. Inherit. Metab. Dis. pmid:12555947
Korman SH et al. Characteristic urine organic acid profile in peroxisomal biogenesis disorders. 2000 J. Inherit. Metab. Dis. pmid:10896310
Robins EJ et al. Effect of dicarboxylic acids on Harding-Passey and Cloudman S91 melanoma cells in tissue culture. 1985 J. Invest. Dermatol. pmid:4031537
Melnik BC et al. Anti-acne agents attenuate FGFR2 signal transduction in acne. 2009 J. Invest. Dermatol. pmid:19225542
Detmar M et al. Effects of azelaic acid on proliferation and ultrastructure of mouse keratinocytes in vitro. 1989 J. Invest. Dermatol. pmid:2473140
Robins EJ et al. Effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent. 1986 J. Invest. Dermatol. pmid:3734479
Ward BJ et al. Effect of L-carnitine on cultured murine melanoma cells exposed to azelaic acid. 1986 J. Invest. Dermatol. pmid:3745962
Pathak MA et al. An evaluation of the effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent. 1985 J. Invest. Dermatol. pmid:4031538
Leibl H et al. Inhibition of DNA synthesis of melanoma cells by azelaic acid. 1985 J. Invest. Dermatol. pmid:4056455
Nazzaro-Porro M et al. Effect of dicarboxylic acids on lentigo maligna. 1979 J. Invest. Dermatol. pmid:448162
Clark AA et al. Odorants specifically modulate chemotaxis and tissue retention of CD4+ T cells via cyclic adenosine monophosphate induction. 2016 J. Leukoc. Biol. pmid:27154353
Kawai Y et al. Immunochemical detection of a novel lysine adduct using an antibody to linoleic acid hydroperoxide-modified protein. 2003 J. Lipid Res. pmid:12700336
Passi S et al. Metabolism of straight saturated medium chain length (C9 to C12) dicarboxylic acids. 1983 J. Lipid Res. pmid:6631243
Januszewski AS et al. Chemical modification of proteins during peroxidation of phospholipids. 2005 J. Lipid Res. pmid:15805546
Seidler J et al. Identification and prediction of promiscuous aggregating inhibitors among known drugs. 2003 J. Med. Chem. pmid:14521410
Daverat P et al. Identification and characterization of anti-conjugated azelaic acid antibodies in multiple sclerosis. 1989 J. Neuroimmunol. pmid:2925840
Cluzeau J and Lubell WD Conformationally constrained dipeptide surrogates with aromatic side-chains: synthesis of 4-aryl indolizidin-9-one amino acids by conjugate addition to a common alpha,omega-diaminoazelate enone intermediate. 2004 J. Org. Chem. pmid:14987004
Gwak HS et al. Analgesic effects of intra-nasal enkephalins. 2003 J. Pharm. Pharmacol. pmid:14604463
Zheng P et al. A novel urinary metabolite signature for diagnosing major depressive disorder. 2013 J. Proteome Res. pmid:24224655
Staroverov SA et al. Biodynamic parameters of micellar diminazene in sheep erythrocytes and blood plasma. 2011 J. Vet. Sci. pmid:22122895
Tacchino RM et al. Short-term infusion of azelaic acid vs intralipid in healthy subjects evaluated by indirect calorimetry. 1990 Mar-Apr JPEN J Parenter Enteral Nutr pmid:2112625
Mingrone G et al. Preliminary studies of a dicarboxylic acid as an energy substrate in man. 1989 May-Jun JPEN J Parenter Enteral Nutr pmid:2503641
Nazzaro-Porro M et al. Effect of azelaic acid on human malignant melanoma. 1980 Lancet pmid:6103442
Azelaic acid, a new treatment for rosacea. 2004 Mayo Clin Womens Healthsource pmid:15152174
Piquero Martín J et al. [Double-blind clinical study of the treatment of melasma with azelaic acid versus hydroquinone]. 1988 Med Cutan Ibero Lat Am pmid:3073279
Azelaic acid (Finacea) for rosacea. 2003 Med Lett Drugs Ther pmid:12968125
Azelaic acid-a new topical drug for acne. 1996 Med Lett Drugs Ther pmid:8637482
Gollnick H [Azelaic acid for keratinization disorders?]. 1991 Med Monatsschr Pharm pmid:1838401
Breathnach AS Azelaic acid: potential as a general antitumoural agent. 1999 Med. Hypotheses pmid:10362281
Reis CP et al. Development and evaluation of a novel topical treatment for acne with azelaic acid-loaded nanoparticles. 2013 Microsc. Microanal. pmid:23673203
Schnopp C and Mempel M Acne vulgaris in children and adolescents. 2011 Minerva Pediatr. pmid:21909065
Koczorek M ["Cleansing, topical treatment, oral administration". Controlling acne]. 2001 MMW Fortschr Med pmid:11524979
Muthulakshmi S and Saravanan R Protective effects of azelaic acid against high-fat diet-induced oxidative stress in liver, kidney and heart of C57BL/6J mice. 2013 Mol. Cell. Biochem. pmid:23361364
Grammatico P et al. Karyotype modifications in human malignant melanoma cell cultures after treatment with azelaic acid. 1993 Mutat. Res. pmid:7685492
Garelnabi M et al. Evaluation of a gas chromatography method for azelaic acid determination in selected biological samples. 2010 N Am J Med Sci pmid:22558586
Chagnaud JL et al. Monoclonal anti-conjugated azelaic acid antibody production: application to multiple sclerosis. 1990 Neuroreport pmid:2129868
Roebuck HL Face up to rosacea. 2005 Nurse Pract pmid:16151303
U-Taniguchi Y et al. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors. 1995 Oncol. Res. pmid:8555652
Gung BW and Dickson H Total synthesis of (-)-minquartynoic acid: an anti-cancer, anti-HIV natural product. 2002 Org. Lett. pmid:12123365
Preisz K and Kárpáti S [Rosacea: pathogenesis, clinical forms and therapy]. 2010 Orv Hetil pmid:20650811
Culp B and Scheinfeld N Rosacea: a review. 2009 P T pmid:19562004
Goulden V Guidelines for the management of acne vulgaris in adolescents. 2003 Paediatr Drugs pmid:12716217
Jansen T et al. Steroid-induced periorificial dermatitis in children--clinical features and response to azelaic acid. 2010 Mar-Apr Pediatr Dermatol pmid:19804495
Rocchiccioli F et al. Medium- and long-chain dicarboxylic aciduria in patients with Zellweger syndrome and neonatal adrenoleukodystrophy. 1986 Pediatr. Res. pmid:3945517
Herkenne C et al. In vivo methods for the assessment of topical drug bioavailability. 2008 Pharm. Res. pmid:17985216
Pattarino F et al. Topical delivery systems for azelaic acid: effect of the suspended drug in microemulsion. 1994 Pharmazie pmid:8140138
Duteil L and Ortonne JP Colorimetric assessment of the effects of azelaic acid on light-induced skin pigmentation. 1992 Photodermatol Photoimmunol Photomed pmid:1489719
Polis BD et al. Studies on PGBx, a polymeric derivative of prostaglandin B1: I. Synthesis and purification of PGBx. 1979 Physiol. Chem. Phys. pmid:482383
Rodriguez-Vicente J et al. Azelaic acid was sensitizing effect in the chemotherapeutic treatment of several melanoma cell lines. 1996 Pigment Cell Res. pmid:9125756
Chaturvedi R et al. An abietane diterpenoid is a potent activator of systemic acquired resistance. 2012 Plant J. pmid:22385469
Truman WM et al. Arabidopsis auxin mutants are compromised in systemic acquired resistance and exhibit aberrant accumulation of various indolic compounds. 2010 Plant Physiol. pmid:20081042
Zoeller M et al. Lipid profiling of the Arabidopsis hypersensitive response reveals specific lipid peroxidation and fragmentation processes: biogenesis of pimelic and azelaic acid. 2012 Plant Physiol. pmid:22822212
Chaouch S et al. Peroxisomal hydrogen peroxide is coupled to biotic defense responses by ISOCHORISMATE SYNTHASE1 in a daylength-related manner. 2010 Plant Physiol. pmid:20543092
Xia Y et al. The glabra1 mutation affects cuticle formation and plant responses to microbes. 2010 Plant Physiol. pmid:20699396
Lim GH et al. Role of plasmodesmata and plasmodesmata localizing proteins in systemic immunity. 2016 Plant Signal Behav pmid:27645210
Fabbrocini G et al. Skin needling to enhance depigmenting serum penetration in the treatment of melasma. 2011 Plast Surg Int pmid:22567235
Estronca LM et al. Molecular etiology of atherogenesis--in vitro induction of lipidosis in macrophages with a new LDL model. 2012 PLoS ONE pmid:22514671
Gordy JW et al. Comparative Effectiveness of Potential Elicitors of Plant Resistance against Spodoptera frugiperda (J. E. Smith) (Lepidoptera: Noctuidae) in Four Crop Plants. 2015 PLoS ONE pmid:26332833
Vinaixa M et al. Metabolomics reveals reduction of metabolic oxidation in women with polycystic ovary syndrome after pioglitazone-flutamide-metformin polytherapy. 2011 PLoS ONE pmid:22194988
von Schönfels W et al. Metabolic signature of electrosurgical liver dissection. 2013 PLoS ONE pmid:24058442
Elsaie ML and Choudhary S Updates on the pathophysiology and management of acne rosacea. 2009 Postgrad Med pmid:19820288
Scheinfeld N and Berk T A review of the diagnosis and treatment of rosacea. 2010 Postgrad Med pmid:20107297
Mingrone G et al. Influence of sodium salts of saturated medium chain length (C6, C9, C10 and C12) dicarboxylic acids on the uterine horn of rat in vitro. 1988 Q J Exp Physiol pmid:3164112
Lanz C et al. Radiation metabolomics. 3. Biomarker discovery in the urine of gamma-irradiated rats using a simplified metabolomics protocol of gas chromatography-mass spectrometry combined with random forests machine learning algorithm. 2009 Radiat. Res. pmid:19630524
LaFranchi BW et al. Photoelectron resonance capture ionization mass spectrometry: a soft ionization source for mass spectrometry of particle-phase organic compounds. 2004 Rapid Commun. Mass Spectrom. pmid:15468105
Grosshans E and Chartier C [Therapeutic depigmentation agents]. 1987 Schweiz. Rundsch. Med. Prax. pmid:3671942
Parker JE The quest for long-distance signals in plant systemic immunity. 2009 Sci Signal pmid:19436056
Jung HW et al. Priming in systemic plant immunity. 2009 Science pmid:19342588
Han S et al. Application of HPLC with ELSD detection for the assessment of azelaic acid impurities in liposomal formulation. 2013 ScientificWorldJournal pmid:24228008
Helfrich YR and Maier LM Topical and oral therapeutic approach to rosacea. 2016 Semin Cutan Med Surg pmid:27416312
Sieber MA and Hegel JK Azelaic acid: Properties and mode of action. 2014 Skin Pharmacol Physiol pmid:24280644
Vargas-Diez E et al. Azelaic acid in the treatment of acne in adult females: case reports. 2014 Skin Pharmacol Physiol pmid:24280645
Halder RM and Richards GM Topical agents used in the management of hyperpigmentation. 2004 Jun-Jul Skin Therapy Lett. pmid:15334278
Gooderham M Rosacea and its topical management. 2009 Skin Therapy Lett. pmid:19330270
Gupta G et al. Ivermectin 1% cream for rosacea. 2015 Jul-Aug Skin Therapy Lett. pmid:26382711
Fallen RS and Gooderham M Rosacea: update on management and emerging therapies. 2012 Skin Therapy Lett. pmid:23223767
Pazoki-Toroudi H et al. Therapeutic effects of minoxidil high extra combination therapy in patients with androgenetic alopecia. 2012 Sep-Oct Skinmed pmid:23163069
Ganzetti G et al. Rosacea: could topical azelaic acid and oral tetracyclines modify videocapillaroscopic pattern? 2014 Mar-Apr Skinmed pmid:24933858
Sun H et al. Complete genome sequence of Nocardiopsis dassonvillei type strain (IMRU 509). 2010 Stand Genomic Sci pmid:21304737